Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4638260
Max Phase: Preclinical
Molecular Formula: C23H20ClFN4O4S
Molecular Weight: 502.96
Molecule Type: Unknown
Associated Items:
ID: ALA4638260
Max Phase: Preclinical
Molecular Formula: C23H20ClFN4O4S
Molecular Weight: 502.96
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C/C(=N\NC(=O)CNC(=O)c1cccc(S(=O)(=O)Nc2ccccc2Cl)c1)c1ccc(F)cc1
Standard InChI: InChI=1S/C23H20ClFN4O4S/c1-15(16-9-11-18(25)12-10-16)27-28-22(30)14-26-23(31)17-5-4-6-19(13-17)34(32,33)29-21-8-3-2-7-20(21)24/h2-13,29H,14H2,1H3,(H,26,31)(H,28,30)/b27-15+
Standard InChI Key: OYSVLEVFPRQYGD-JFLMPSFJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 502.96 | Molecular Weight (Monoisotopic): 502.0878 | AlogP: 3.55 | #Rotatable Bonds: 8 |
Polar Surface Area: 116.73 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.78 | CX Basic pKa: 0.60 | CX LogP: 2.94 | CX LogD: 2.92 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.32 | Np Likeness Score: -2.26 |
1. Zhao C, Rakesh KP, Ravidar L, Fang WY, Qin HL.. (2019) Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review., 162 [PMID:30496988] [10.1016/j.ejmech.2018.11.017] |
Source(1):